Special Training on Veterinary Drug Products  

Enhance Competitiveness and Embark on a New Journey of Market Breakthrough

In today's highly competitive veterinary drug market, a company's core competitiveness is crucial for its foothold and development. On June 5, 2025, a significant Special Training Session on Veterinary Drug Products was grandly held in the company. This training activity was like a timely rain, laying a solid foundation for comprehensively enhancing the core competitiveness of products and accurately empowering the sales team.

This training was carefully and jointly planned by the Veterinary Drug Marketing Department, the Domestic and Foreign Trade and Formulation Sales Department. The training faculty is truly impressive, with each instructor boasting extensive experience and remarkable achievements in the veterinary drug field. Ma Xiaolong, the Minister of the Veterinary Drug Marketing Department, has deeply engaged in the veterinary drug industry for over a decade and led the market breakthrough of multiple strategic single products. Ji Jianxun, the Domestic Sales Director of Veterinary Drugs, as a frontline practical expert, has successfully established an elite sales system. Their participation provides a strong guarantee for the professionalism and practicality of the training.

The core content of the training, which deeply decoded key aspects, was particularly exciting. In the module of panoramic analysis of strategic single products lectured by Minister Ma Xiaolong, an in-depth interpretation was first given to the technology-leading product matrix. For example, in the case of Youmeihong™ Erythromycin Thiocyanate, significant breakthroughs have been made in its purification process and bioavailability; Xiyangyang™ Tiamulin Fumarate has strengthened clinical protocols in terms of stability; and Fudaoshen® Low B Lincomycin Hydrochloride has become a benchmark in impurity control technology. In terms of forging high-end brand value, multiple invention patents were deeply interpreted, and these patented technologies have built industry barriers. The four-dimensional confidence system covers full-chain empowerment in branding, products, sales, and services, while the deconstruction of terminal sales rhetoric has achieved the transformation from product advantages to customer value.

The practical guide to pharmaceutical products lectured by Director Ji Jianxun is equally remarkable. The display of the application scenario map for full-category pharmaceuticals allows trainees to gain a clearer understanding of the application of pharmaceutical products; the explanation of breakthrough strategies through competitive product benchmarking helps stand out in market competition; and the construction of a precise solution library for customer pain points directly addresses market demands.

In the strategic policy implementation session, the company's latest strategic guidance was deeply interpreted to enable all participating employees to clarify the development direction. The reconstruction of the market expense investment logic and the explanation of the implementation path for the customer classification management mechanism provided a scientific basis for market operations.

The effect of empowering all employees has been remarkable. The training covered six core departments, including the Veterinary Drug Domestic Trade Department, Veterinary Drug Foreign Trade Department, Pharmaceutical R&D Department, Pet Products Department, Human Resources Recruitment Department, and New Media Task Force. The scale of participants has set a new annual record for special training.

In terms of training outcomes, the achievements are substantial. An upgrade has been realized in product cognition, with the establishment of a three-dimensional knowledge network integrating technical parameters, clinical value, and market positioning. Policies are implemented with full penetration, ensuring that strategic intentions reach 100% of the operational grassroots. The combat capability system has been activated, and the iteration of Version 3.0 of the sales rhetoric toolbox has been completed. As feedback from participating trainees in practical operations stated: "This training is not merely knowledge imparting, but rather the installation of a 'nuclear-powered engine' for market breakthroughs!"

With the full alignment of the product knowledge system and policy implementation standards, the Veterinary Drug Business Division has entered a new stage of combat readiness upgrading. All personnel will take technological confidence as the spear and brand confidence as the shield to fully advance the achievement of sales targets in the 2025 market breakthrough campaign. We also look forward to more people paying attention to the training zone on the official website, obtaining course essence materials, and jointly witnessing the vigorous development of the enterprise in the veterinary drug market.